Home › Colorectal Cancer › Colorado › Aurora
Colorectal Cancer clinical trials in Aurora, CO
33 studies for Colorectal Cancer are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
RecruitingPhase 1
- UCHealth University of Colorado Hospital, Aurora
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
RecruitingPhase 1
- University of Colorado Cancer Center, Aurora
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- University of Colorado, Aurora
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
RecruitingPhase 3
- Clinical Study Site, Aurora
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Rocky Mountain Cancer Centers-Aurora, Aurora
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
RecruitingPhase 3
- University of Colorado Denver Anschultz Medical Campus, Aurora
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
RecruitingPhase 1
- University of Colorado Denver Anschultz Medical Campus, Aurora
LYL273 for Patients With Relapsed or Refractory mCRC
RecruitingPhase 1/2
- University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
RecruitingPhase 3
- Sarah Cannon Research Institute Scri Oncology Partners, Aurora
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
RecruitingPhase 1/2
- University of Colorado Anschutz Medical Campus ( Site 0299), Aurora
- University of Colorado Anschutz Medical Campus ( Site 0325), Aurora
- University of Colorado Anschutz Medical Campus ( Site 0326), Aurora
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
RecruitingPhase 1/2
- GSK Investigational Site, Aurora
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
RecruitingPhase 3
- Rocky Mountain Cancer Centers - Aurora /ID# 280112, Aurora
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RecruitingPhase 1/2
- University of Colorado - Aurora Cancer Center, Aurora
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Rocky Mountain Cancer Centers, LLP, Aurora
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- University of Colorado, Aurora
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Recruiting
- University of Colorado, Aurora
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
RecruitingPhase 3
- UCHealth University of Colorado Hospital, Aurora
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RecruitingPhase 1/2
- University of Colorado Hospital-Anschutz Cancer Pavilion, Aurora
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- University of Colorado Cancer Center, Aurora
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
RecruitingPhase 1/2
- GSK Investigational Site, Aurora
Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
RecruitingPhase 1/2
- UCHealth University of Colorado Hospital, Aurora
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecruitingPhase 1/2
- Children's Hospital Colorado, Aurora
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
RecruitingObservational studyHealthy volunteers welcome
- University of Colorado Denver, Aurora
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
RecruitingPhase 2
- University of Colorado Hospital- Anschutz Cancer Center Pavillion (ACP), Aurora
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
RecruitingObservational study
- University of Colorado Anschutz Medical Center, Aurora
Novel Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer
RecruitingHealthy volunteers welcome
- University of Colorado Hospital, Aurora
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
RecruitingPhase 1
- University of Colorado, Aurora
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
RecruitingPhase 3
- Rocky Mountain Cancer Centers, LLP, Aurora
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
RecruitingPhase 1
- University of Colorado Hospital - Anschutz Cancer Pavilion (ACP), Aurora
- University of Colorado Hospital, Aurora
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RecruitingPhase 1
- University of Colorado - Aurora Cancer Center, Aurora
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
RecruitingPhase 1/2
- University of Colorado Cancer Center, Aurora
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
RecruitingHealthy volunteers welcome
- DARTNet Institute, Aurora
About Colorectal Cancer
Colorectal cancer starts in the colon or rectum. It may not cause symptoms at first. Screening tests can help find it early, when treatment is most effective.
More about Colorectal Cancer on MedlinePlus
Colorectal Cancer trials in other cities
- Houston, TX101 studies
- New York City, NY86 studies
- Nashville, TN67 studies
- Boston, MA62 studies
- Los Angeles, CA61 studies
- Arlington, VA54 studies
- St. Louis, MO51 studies
- San Antonio, TX43 studies
- Philadelphia, PA41 studies
- Grand Rapids, MI40 studies
- Baldwin Park, CA37 studies
- Tampa, FL36 studies
Other studies in Aurora
- Cancer (all types)34 studies
- Non-Small Cell Lung Cancer31 studies
- Breast Cancer30 studies
- Type 1 Diabetes26 studies
- Metastatic Cancer24 studies
- Ovarian Cancer23 studies
- Obesity20 studies
- Lung Cancer19 studies
- Melanoma18 studies
- Heart Failure17 studies
- Prostate Cancer17 studies
- Acute Myeloid Leukemia16 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.